We are live on ! Find out more
KIA

Kopp Investment Advisors Portfolio holdings

AUM $54.4M
1-Year Est. Return 14.33%
This Fund
S&P 500
This Quarter Est. Return
+9.66%
1 Year Est. Return
+14.33%
3 Year Est. Return
+109.21%
5 Year Est. Return
+340.72%
10 Year Est. Return
–
AUM
$102M
AUM Growth
+$7.6M
Cap. Flow
-$111K
Cap. Flow %
-0.11%
Top 10 Hldgs %
45.07%
Holding
63
New
2
Increased
19
Reduced
34
Closed
2

Top Buys

Rank Stock Value
1
AKRX
Akorn Inc
AKRX
+$1.86M
2
GIMO
Gigamon Inc.
GIMO
+$1.18M
3
CVLT icon
Commault Systems
CVLT
+$778K
4
SRGA
Surgalign Holdings, Inc. Common Stock
SRGA
+$354K
5
ENZ
Enzo Biochem, Inc.
ENZ
+$216K

Top Sells

Rank Stock Value
1
IL
IntraLinks Holdings Inc.
IL
+$2.05M
2
ARRY
Array Biopharma Inc
ARRY
+$1.03M
3
ATRC icon
AtriCure
ATRC
+$1.02M
4
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
+$204K
5
NXTM
NxStage Medical Inc.
NXTM
+$152K

Sector Composition

Rank Sector Weight
1 Healthcare 46.3%
2 Technology 37.9%
3 Industrials 3.2%
4 Financials 2.85%
5 Miscellaneous 2.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VTI icon
51
Vanguard Morningstar Total Stock Market ETF
VTI
$689B
$437K 0.43%
3,600
– –
QQQ icon
52
Invesco QQQ Trust
QQQ
$493B
$391K 0.38%
2,950
– –
VCSH icon
53
Vanguard Short-Term Corporate Bond ETF
VCSH
$45.1B
$319K 0.31%
4,000
– –
TVTY
54
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$292K 0.29%
10,023
+1,205
+14% +$31.8K
GE icon
55
GE Aerospace
GE
$356B
$258K 0.25%
1,807
– –
EGRX
56
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$253K 0.25%
3,050
-855
-22% -$63.6K
TECH icon
57
Bio-Techne
TECH
$11.4B
$203K 0.2%
8,000
– –
EW icon
58
Edwards Lifesciences
EW
$51.8B
$201K 0.2%
6,396
-270
-4% -$8.45K
ENTL
59
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
$163K 0.16%
+11,819
New +$190K
VCEL icon
60
Vericel Corp
VCEL
$2.11B
$154K 0.15%
+55,040
New +$156K
ELGX
61
DELISTED
Endologix Inc
ELGX
$142K 0.14%
1,968
+632
+47% +$41.8K
SYNH
62
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
– –
-3,876
Closed -$204K
IL
63
DELISTED
IntraLinks Holdings Inc.
IL
– –
-151,833
Closed -$2.05M
1 2
3

Similar funds

OPPM
Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return
GX
Greylock XII Menlo Park, California $51.9M AUM 11.52% 1-Year Est. Return
PGA
Premia Global Advisors Coral Gables, Florida $57.9M AUM 2.91% 1-Year Est. Return
SCG
Saban Capital Group Los Angeles, California $59.5M AUM 3.83% 1-Year Est. Return
TCMV
Technology Crossover Management VI Menlo Park, California $59.6M AUM 18.81% 1-Year Est. Return
FCM
Farmstead Capital Management Ridgewood, New Jersey $49M AUM 10.57% 1-Year Est. Return
SAM
Sheffield Asset Management Chicago, Illinois $48.1M AUM 12.96% 1-Year Est. Return
ACP
Aquiline Capital Partners New York $46.9M AUM 5.65% 1-Year Est. Return

Kopp Investment Advisors's Q1 2017 Portfolio in Review

As of Q1 2017, Kopp Investment Advisors held 63 positions worth $102M, up 8% from $94.7M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Kopp Investment Advisors's Q1 2017 filing shows 2 new, 19 increased, 34 reduced and 2 closed positions. Its largest new stake was Entellus Medical, Inc. Common Stock: 11,819 shares worth $163K. The largest sale was IntraLinks Holdings Inc., an estimated $2.05M.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, up from 44% a quarter earlier, followed by Technology and Industrials.

  • Kopp Investment Advisors's largest Q1 2017 buy was Entellus Medical, Inc. Common Stock: 11,819 shares worth $163K.
  • Kopp Investment Advisors added most to Akorn Inc in Q1 2017, an estimated $1.86M increase.
  • Kopp Investment Advisors's biggest Q1 2017 reduction was Array Biopharma Inc, cutting an estimated $1.03M.
  • Kopp Investment Advisors fully exited IntraLinks Holdings Inc. in Q1 2017, selling an estimated $2.05M.
  • Kopp Investment Advisors's ten largest holdings make up 45% of its $102M portfolio in Q1 2017.
  • Kopp Investment Advisors opened 2 new positions and closed 2 in Q1 2017.
  • Kopp Investment Advisors's portfolio value rose 8% quarter-over-quarter to $102M.

Based on Kopp Investment Advisors's 13F filing for Q1 2017, filed 15 May 2017.